| NTRA |
Natera, Inc. |
19.02B |
5.86% |
|
|
|
|
|
140.66 |
-0.59% |
53.42% |
33.99% |
|---|
| VCYT |
Veracyte, Inc. |
2.50B |
5.41% |
|
|
|
|
|
32.02 |
-1.51% |
62.23% |
51.09% |
|---|
| QGEN |
Qiagen N.V. |
8.65B |
4.66% |
|
|
|
|
|
39.75 |
-0.33% |
48.39% |
62.31% |
|---|
| TECH |
Bio-Techne Corporation |
10.18B |
4.57% |
|
|
|
|
|
64.37 |
1.55% |
40.49% |
42.76% |
|---|
| BNTX |
BioNTech SE |
26.08B |
4.45% |
|
|
|
|
|
108.78 |
-1.85% |
45.15% |
88.94% |
|---|
| A |
Agilent Technologies, Inc. |
36.12B |
4.42% |
|
|
|
|
|
126.70 |
0.12% |
26.04% |
43.42% |
|---|
| BMRN |
BioMarin Pharmaceutical Inc. |
13.78B |
4.10% |
|
|
|
|
|
72.23 |
1.43% |
33.04% |
21.11% |
|---|
| ARWR |
Arrowhead Pharmaceuticals, Inc. |
2.14B |
4.10% |
|
|
|
|
|
16.97 |
-3.96% |
56.04% |
76.28% |
|---|
| ILMN |
Illumina, Inc. |
13.72B |
4.09% |
|
|
|
|
|
86.62 |
2.33% |
48.72% |
48.69% |
|---|
| SRPT |
Sarepta Therapeutics, Inc. |
10.00B |
4.09% |
|
|
|
|
|
103.03 |
-2.40% |
50.24% |
14.78% |
|---|
| BEAM |
Beam Therapeutics Inc. |
2.38B |
3.76% |
|
|
|
|
|
28.48 |
4.51% |
63.92% |
88.99% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.91B |
3.68% |
|
|
|
|
|
45.53 |
5.13% |
50.49% |
33.91% |
|---|
| ALNY |
Alnylam Pharmaceuticals, Inc. |
31.65B |
3.51% |
|
|
|
|
|
244.52 |
-1.45% |
41.52% |
39.03% |
|---|
| RARE |
Ultragenyx Pharmaceutical Inc. |
3.57B |
3.39% |
|
|
|
|
|
38.62 |
-3.50% |
71.90% |
22.87% |
|---|
| LEGN |
Legend Biotech Corporation |
3.23B |
3.27% |
|
|
|
|
|
35.26 |
3.16% |
65.05% |
41.89% |
|---|
| MRNA |
Moderna, Inc. |
13.74B |
3.23% |
|
|
|
|
|
35.61 |
3.82% |
79.88% |
71.47% |
|---|
| TXG |
10x Genomics, Inc. |
1.43B |
2.97% |
|
|
|
|
|
11.70 |
2.01% |
81.27% |
80.67% |
|---|
| RNA |
Avidity Biosciences, Inc. |
3.64B |
2.82% |
|
|
|
|
|
30.29 |
-0.20% |
67.15% |
76.34% |
|---|
| 1548.HK |
GENSCRIPT BIOTECH CORP |
|
2.76% |
|
|
|
|
|
|
|
|
|
|---|
| MYGN |
Myriad Genetics, Inc. |
929.53M |
2.47% |
|
|
|
|
|
10.18 |
-3.23% |
60.35% |
78.80% |
|---|
| NTLA |
Intellia Therapeutics, Inc. |
1.07B |
2.36% |
|
|
|
|
|
10.35 |
4.55% |
84.48% |
69.93% |
|---|
| GILD |
Gilead Sciences, Inc. |
146.22B |
2.31% |
|
|
|
|
|
117.41 |
1.18% |
26.32% |
39.54% |
|---|
| CDNA |
CareDx, Inc |
1.05B |
2.17% |
|
|
|
|
|
18.92 |
0.11% |
110.71% |
34.67% |
|---|
| RCKT |
Rocket Pharmaceuticals, Inc. |
935.15M |
2.09% |
|
|
|
|
|
8.77 |
-2.45% |
217.96% |
80.68% |
|---|
| VRTX |
Vertex Pharmaceuticals Incorporated |
125.39B |
1.87% |
|
|
|
|
|
488.29 |
0.53% |
27.80% |
27.21% |
|---|
| QURE |
uniQure N.V. |
661.36M |
1.59% |
|
|
|
|
|
12.23 |
-2.24% |
62.26% |
32.91% |
|---|
| VIR |
Vir Biotechnology, Inc. |
1.09B |
1.34% |
|
|
|
|
|
7.96 |
-1.36% |
70.90% |
55.94% |
|---|
| MRVI |
Maravai LifeSciences Holdings, Inc. |
419.86M |
1.33% |
|
|
|
|
|
2.9600 |
10.86% |
326.40% |
68.91% |
|---|
| PSTX |
POSEIDA THERAPEUTICS INC |
|
1.26% |
|
|
|
|
|
|
|
|
|
|---|
| SGMO |
Sangamo Therapeutics, Inc. |
216.99M |
0.96% |
|
|
|
|
|
1.0400 |
4.00% |
152.43% |
44.62% |
|---|
| PACB |
Pacific Biosciences of California, Inc. |
364.24M |
0.95% |
|
|
|
|
|
1.3300 |
2.31% |
120.73% |
43.54% |
|---|
| FLGT |
Fulgent Genetics, Inc. |
573.12M |
0.75% |
|
|
|
|
|
18.59 |
3.85% |
88.61% |
27.60% |
|---|
| VERV |
Verve Therapeutics, Inc. |
595.82M |
0.71% |
|
|
|
|
|
6.71 |
1.51% |
154.23% |
35.87% |
|---|
| RGNX |
REGENXBIO Inc. |
314.12M |
0.66% |
|
|
|
|
|
6.34 |
-1.71% |
652.49% |
47.13% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
457.08M |
0.59% |
|
|
|
|
|
2.1800 |
7.92% |
677.77% |
63.91% |
|---|
| SANA |
Sana Biotechnology, Inc. |
576.03M |
0.40% |
|
|
|
|
|
2.5800 |
1.18% |
214.00% |
40.52% |
|---|
| TSVT |
2seventy bio, Inc. |
137.23M |
0.29% |
|
|
|
|
|
2.6600 |
-6.99% |
368.39% |
30.03% |
|---|
| CRBU |
Caribou Biosciences, Inc. |
105.04M |
0.27% |
|
|
|
|
|
1.1600 |
-0.43% |
1,000.13% |
72.56% |
|---|
| EDIT |
Editas Medicine, Inc. |
142.72M |
0.20% |
|
|
|
|
|
1.7200 |
-3.37% |
146.68% |
47.86% |
|---|
| LYEL |
Lyell Immunopharma, Inc. |
217.13M |
0.17% |
|
|
|
|
|
0.7432 |
2.31% |
279.25% |
27.47% |
|---|
| E |
Eni S.p.A. |
46.84B |
0.01% |
|
|
|
|
|
29.45 |
2.94% |
34.22% |
47.19% |
|---|